Search research articles
Contact Us
Filters
Showing results (11-20 of 56) with videos related to
Page
of 6
Sort By:
BMC Health Services Research
|
August 17, 2012
Effects of proactive population-based nephrologist oversight on progression of chronic kidney disease: a retrospective control analysis
Brian Lee, Marianne Turley, Di Meng, et al.
Oncotarget
|
October 31, 2015
The orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of cisplatin to resolve ATM-deficient non-small cell lung cancer in vivo
Frank P Vendetti, Alan Lau, Sandra Schamus, et al.
Lancet (London, England)
|
August 28, 2015
Synthetic lethality in chronic lymphocytic leukaemia with DNA damage response defects by targeting the ATR pathway
Marwan Kwok, Nicholas Davies, Angelo Agathanggelou, et al.
Nature Cell Biology
|
April 19, 2005
Suppression of HIV-1 infection by a small molecule inhibitor of the ATM kinase
Alan Lau, Karra M Swinbank, Parvin S Ahmed, et al.
Communications Biology
|
August 25, 2021
Tumour-on-chip microfluidic platform for assessment of drug pharmacokinetics and treatment response
Tudor Petreus, Elaine Cadogan, Gareth Hughes, et al.
Molecular Cancer Therapeutics
|
March 21, 2013
Preclinical evaluation of a novel ATM inhibitor, KU59403, in vitro and in vivo in p53 functional and dysfunctional models of human cancer
Michael A Batey, Yan Zhao, Suzanne Kyle, et al.
Mededpublish (2016)
|
March 15, 2024
A three-year post-graduate Doctorate in Pharmacy course incorporating professional, experiential and research activities: A collaborative innovative approach
Janis Vella, Maresca Attard Pizzuto, Nicolette Sammut Bartolo, et al.
Cell Cycle (Georgetown, Tex.)
|
September 18, 2012
Evaluation of candidate biomarkers to predict cancer cell sensitivity or resistance to PARP-1 inhibitor treatment
Lenka Oplustilova, Kamila Wolanin, Martin Mistrik, et al.
British Journal of Cancer
|
August 4, 2020
Complete loss of ATM function augments replication catastrophe induced by ATR inhibition and gemcitabine in pancreatic cancer models
Charles R Dunlop, Yann Wallez, Timothy Isaac Johnson, et al.
Oncogene
|
April 12, 2018
BRD4 facilitates replication stress-induced DNA damage response
Jingwen Zhang, Austin M Dulak, Maureen M Hattersley, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 56) with videos related to
Sort By:
Page
of 6
BMC Health Services Research
|
August 17, 2012
Effects of proactive population-based nephrologist oversight on progression of chronic kidney disease: a retrospective control analysis
Brian Lee, Marianne Turley, Di Meng, et al.
Oncotarget
|
October 31, 2015
The orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of cisplatin to resolve ATM-deficient non-small cell lung cancer in vivo
Frank P Vendetti, Alan Lau, Sandra Schamus, et al.
Lancet (London, England)
|
August 28, 2015
Synthetic lethality in chronic lymphocytic leukaemia with DNA damage response defects by targeting the ATR pathway
Marwan Kwok, Nicholas Davies, Angelo Agathanggelou, et al.
Nature Cell Biology
|
April 19, 2005
Suppression of HIV-1 infection by a small molecule inhibitor of the ATM kinase
Alan Lau, Karra M Swinbank, Parvin S Ahmed, et al.
Communications Biology
|
August 25, 2021
Tumour-on-chip microfluidic platform for assessment of drug pharmacokinetics and treatment response
Tudor Petreus, Elaine Cadogan, Gareth Hughes, et al.
Molecular Cancer Therapeutics
|
March 21, 2013
Preclinical evaluation of a novel ATM inhibitor, KU59403, in vitro and in vivo in p53 functional and dysfunctional models of human cancer
Michael A Batey, Yan Zhao, Suzanne Kyle, et al.
Mededpublish (2016)
|
March 15, 2024
A three-year post-graduate Doctorate in Pharmacy course incorporating professional, experiential and research activities: A collaborative innovative approach
Janis Vella, Maresca Attard Pizzuto, Nicolette Sammut Bartolo, et al.
Cell Cycle (Georgetown, Tex.)
|
September 18, 2012
Evaluation of candidate biomarkers to predict cancer cell sensitivity or resistance to PARP-1 inhibitor treatment
Lenka Oplustilova, Kamila Wolanin, Martin Mistrik, et al.
British Journal of Cancer
|
August 4, 2020
Complete loss of ATM function augments replication catastrophe induced by ATR inhibition and gemcitabine in pancreatic cancer models
Charles R Dunlop, Yann Wallez, Timothy Isaac Johnson, et al.
Oncogene
|
April 12, 2018
BRD4 facilitates replication stress-induced DNA damage response
Jingwen Zhang, Austin M Dulak, Maureen M Hattersley, et al.
Page
of 6